Gene fusions may be the 'smoking gun' in prostate cancer development
Tuesday, May 18, 2010 - 13:31
in Health & Medicine
Prostate cancer treatments that target the hormone androgen and its receptor may be going after the wrong source, according to a new study. Researchers have found that when two genes fuse together to cause prostate cancer, it blocks the receptor for the hormone androgen, preventing prostate cells from developing normally.